Correlation Between Eupraxia Pharmaceuticals and Biotricity

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eupraxia Pharmaceuticals and Biotricity at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eupraxia Pharmaceuticals and Biotricity into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eupraxia Pharmaceuticals Common and Biotricity, you can compare the effects of market volatilities on Eupraxia Pharmaceuticals and Biotricity and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eupraxia Pharmaceuticals with a short position of Biotricity. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eupraxia Pharmaceuticals and Biotricity.

Diversification Opportunities for Eupraxia Pharmaceuticals and Biotricity

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Eupraxia and Biotricity is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Eupraxia Pharmaceuticals Commo and Biotricity in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotricity and Eupraxia Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eupraxia Pharmaceuticals Common are associated (or correlated) with Biotricity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotricity has no effect on the direction of Eupraxia Pharmaceuticals i.e., Eupraxia Pharmaceuticals and Biotricity go up and down completely randomly.

Pair Corralation between Eupraxia Pharmaceuticals and Biotricity

If you would invest  299.00  in Eupraxia Pharmaceuticals Common on October 21, 2024 and sell it today you would earn a total of  21.00  from holding Eupraxia Pharmaceuticals Common or generate 7.02% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy0.0%
ValuesDaily Returns

Eupraxia Pharmaceuticals Commo  vs.  Biotricity

 Performance 
       Timeline  
Eupraxia Pharmaceuticals 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Eupraxia Pharmaceuticals Common are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Eupraxia Pharmaceuticals showed solid returns over the last few months and may actually be approaching a breakup point.
Biotricity 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotricity has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, Biotricity is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Eupraxia Pharmaceuticals and Biotricity Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eupraxia Pharmaceuticals and Biotricity

The main advantage of trading using opposite Eupraxia Pharmaceuticals and Biotricity positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eupraxia Pharmaceuticals position performs unexpectedly, Biotricity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotricity will offset losses from the drop in Biotricity's long position.
The idea behind Eupraxia Pharmaceuticals Common and Biotricity pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.

Other Complementary Tools

Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Stocks Directory
Find actively traded stocks across global markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio